Clinical Trial Update: Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating lapaquistat acetate alone or with high-dose statin in hypercholesterolemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)

Snippet

Sponsor: Takeda | Conditions: Hypercholesterolemia | Phase 3 | Status: TERMINATED